Please select the option that best describes you:
Would you give EP chemotherapy to a patient with Stage IIA nonseminoma with negative markers who underwent RPLND and had pN2 disease with predominant teratoma?
Would you think differently about chemotherapy based on %teratoma or size of lymph nodes vs number of lymph nodes (eg. multiple small LN vs single 2-5cm mass)?
Answer from: Medical Oncologist at Community Practice
For CS IIA disease undergoing open RPLND by an experienced urologist, the long time practice of the groups that I have the fortune to work with closely has been to not given adjuvant therapy since there is a substantial chance of obtaining cure with surgery alone without any chemotherapy. The upstag...
Sign in or Register to read more